ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 82 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,120,000 | -73.3% | 511,579 | -26.8% | 0.04% | -72.6% |
| Q1 2019 | $4,189,000 | +4.7% | 699,307 | +29.2% | 0.14% | -7.5% |
| Q4 2018 | $4,000,000 | -29.4% | 541,251 | +38.8% | 0.15% | -28.1% |
| Q3 2018 | $5,663,000 | -29.0% | 389,997 | -2.3% | 0.20% | -30.0% |
| Q2 2018 | $7,975,000 | +114.9% | 399,342 | +88.5% | 0.29% | +100.0% |
| Q1 2018 | $3,711,000 | +128.7% | 211,797 | +221.8% | 0.14% | +126.6% |
| Q4 2017 | $1,623,000 | +51.5% | 65,809 | +58.6% | 0.06% | +36.2% |
| Q3 2017 | $1,071,000 | -7.9% | 41,484 | -3.2% | 0.05% | -7.8% |
| Q2 2017 | $1,163,000 | +11.9% | 42,869 | +23.1% | 0.05% | 0.0% |
| Q1 2017 | $1,039,000 | +10.2% | 34,827 | +0.3% | 0.05% | +6.2% |
| Q4 2016 | $943,000 | – | 34,734 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |